Mercier C - Search Results

1

In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants.

Jacqueroux E, Mercier C, Margelidon-Cozzolino V, Hodin S, Bertoletti L, Delavenne X. Jacqueroux E, et al. Among authors: mercier c. Fundam Clin Pharmacol. 2020 Feb;34(1):109-119. doi: 10.1111/fcp.12504. Epub 2019 Aug 28. Fundam Clin Pharmacol. 2020. PMID: 31411766

2

Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Mercier C, Perek N, Delavenne X. Mercier C, et al. Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):13-24. doi: 10.1007/s13318-017-0426-x. Eur J Drug Metab Pharmacokinet. 2018. PMID: 28688000 Review.

3

Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs.

Mercier C, Hodin S, He Z, Perek N, Delavenne X. Mercier C, et al. Mol Pharm. 2018 Jun 4;15(6):2246-2256. doi: 10.1021/acs.molpharmaceut.8b00087. Epub 2018 May 10. Mol Pharm. 2018. PMID: 29709196

4

Pharmacological characterization of the 3D MucilAir™ nasal model.

Mercier C, Jacqueroux E, He Z, Hodin S, Constant S, Perek N, Boudard D, Delavenne X. Mercier C, et al. Eur J Pharm Biopharm. 2019 Jun;139:186-196. doi: 10.1016/j.ejpb.2019.04.002. Epub 2019 Apr 3. Eur J Pharm Biopharm. 2019. PMID: 30951820

5

TNF-α and IL-1β Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barriers.

Saib S, Hodin S, Mercier C, Paul M, Bin V, Ollier E, Delavenne X. Saib S, et al. Among authors: mercier c. Mol Pharm. 2022 Jul 4;19(7):2327-2334. doi: 10.1021/acs.molpharmaceut.2c00140. Epub 2022 Jun 8. Mol Pharm. 2022. PMID: 35674492

6

In Vitro Biological Effects of E-Cigarette on the Cardiovascular System-Pro-Inflammatory Response Enhanced by the Presence of the Cinnamon Flavor.

Michon M, Mercier C, Petit C, Leclerc L, Bertoletti L, Pourchez J, Forest V. Michon M, et al. Among authors: mercier c. Toxics. 2022 Dec 14;10(12):784. doi: 10.3390/toxics10120784. Toxics. 2022. PMID: 36548617 Free PMC article.

7

Considerations on dosimetry for in vitro assessment of e-cigarette toxicity.

Forest V, Mercier C, Pourchez J. Forest V, et al. Among authors: mercier c. Respir Res. 2022 Dec 17;23(1):358. doi: 10.1186/s12931-022-02286-1. Respir Res. 2022. PMID: 36528600 Free PMC article. Review.

8

From smoking to vaping: a new environmental threat?

Pourchez J, Mercier C, Forest V. Pourchez J, et al. Among authors: mercier c. Lancet Respir Med. 2022 Jul;10(7):e63-e64. doi: 10.1016/S2213-2600(22)00187-4. Epub 2022 May 23. Lancet Respir Med. 2022. PMID: 35617988 No abstract available.

9

The recent explosion in snortable energy powder consumption.

Pourchez J, Mercier C, Leclerc L, Forest V. Pourchez J, et al. Among authors: mercier c. Lancet Respir Med. 2024 Aug;12(8):e47. doi: 10.1016/S2213-2600(24)00188-7. Lancet Respir Med. 2024. PMID: 39089763 No abstract available.

10

The Ability of Vaping Technology to Deliver an Equivalent Respirable Dose of Beclomethasone Dipropionate Compared to Nebulization.

Bruneau C, Mercier C, Leclerc L, Pourchez J. Bruneau C, et al. Among authors: mercier c. Pharmaceutics. 2024 Oct 30;16(11):1396. doi: 10.3390/pharmaceutics16111396. Pharmaceutics. 2024. PMID: 39598520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

752 results

Search Page

Filters